Benzyl-PEG3-Mes manufacturers
- Benzyl-PEG2-Ms
-
-
2025-06-07
- CAS:150272-33-6
- Min. Order: 1g
- Purity: >98.00%
- Supply Ability: 1g
|
| | Benzyl-PEG3-Mes Basic information |
| Product Name: | Benzyl-PEG3-Mes | | Synonyms: | Benzyl-PEG2-Mes;Benzyl-PEG2-MS;Benzyl-PEG3-Mes;CAS_150272-33-6;di(ethylene glycol)monobenzyl ether methanesulfonate;Ethanol, 2-[2-(phenylmethoxy)ethoxy]-, 1-methanesulfonate;2-(2-Phenylmethoxyethoxy)ethyl methanesulfonate;Ethanol, 2-[2-(phenylmethoxy)ethoxy]-, methanesulfonate | | CAS: | 150272-33-6 | | MF: | C12H18O5S | | MW: | 274.33 | | EINECS: | | | Product Categories: | | | Mol File: | 150272-33-6.mol |  |
| | Benzyl-PEG3-Mes Chemical Properties |
| | Benzyl-PEG3-Mes Usage And Synthesis |
| Uses | Benzyl-PEG2-MS is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. | | Biological Activity | Benzyl-PEG2-MS is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].
PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1]. | | IC 50 | PEGs | | References | [1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 |
| | Benzyl-PEG3-Mes Preparation Products And Raw materials |
|